Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rectal versus sublingual misoprostol for postpartum hemorrhage prevention during cesarean section
IRCT20190204042614N1Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- May 2018
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of misoprostol and oxytocin in postpartum hemorrhage (PPH) (2 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoint: Count of bleeding during and after cesarean delivery. Started May 2018; status: completed.
02
Drugs
misoprostoloxytocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on IRCT20190204042614N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190204042614N1.